Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (2) , 157-163
- https://doi.org/10.1016/0732-8893(89)90007-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Emergence of Coagulase Negative Staphylococci as Major Nosocomial Bloodstream PathogensInfection Control, 1987
- Clinical trial of the efficacy and safety of ticarcillin and clavulanic acidAntimicrobial Agents and Chemotherapy, 1985
- In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolatesAntimicrobial Agents and Chemotherapy, 1984
- Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other β-lactamsJournal of Antimicrobial Chemotherapy, 1984
- Susceptibility of gram-negative bacteria andStaphylococcus aureus to combinations of ticarcillin and clavulanic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1982
- Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenesInfection, 1979
- Clavulanic Acid, a Novel Inhibitor of β-LactamasesAntimicrobial Agents and Chemotherapy, 1978
- A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related InfectionNew England Journal of Medicine, 1977
- The β-Lactamases of Gram-Negative Bacteria and their Possible Physiological RolePublished by Elsevier ,1973